Contact
Advances in materials science and engineering are key components of the innovation process. In this four-part series we highlight areas of materials research driving breakthroughs in technology.
Cancer precision medicine seeks to match each individual patient to the most effective available therapy. To date, precision medicine has largely been based on genomic profiling, in which patients with certain pre-defined genetic alterations are identified and matched with drugs targeting those specific abnormalities. Despite early success, progress in identifying additional actionable mutations has been slow, and today less than 20% of patients with metastatic cancer are eligible for FDA-approved genome-guided drugs. How can this be improved? What alternative approaches might there be?
Following last year's successful Silicon Valley Showcase, MIT Startup Exchange is once again excited to feature this October countless advances in innovation, entrepreneurship and industry collaboration to impact not only how companies can do business but also how we function in our daily lives. What exciting new innovations are emerging from the MIT startup ecosystem? How will the latest technology trends affect your business? How can startups help transform a difficult landscape under COVID-19 and beyond? MIT Startup Exchange, an integrated program of MIT Corporate Relations, is hosting a Startup Showcase to feature West Coast startups and their technologies focused on AI and IoT, finance, customer analytics, energy, supply chain and manufacturing, among other key themes. Join us, as this promises to be an excellent forum where potential partnerships between corporates and startups can emerge!